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Abstract
Background: Drug use can lead to several psychological, medical and social complications. The current study
aimed to measure and decomposes socioeconomic-related inequalities in drug use among adults in Iran.
Methods: This was a cross-sectional study The PERSIAN Cohort is the largest and most important cohort among 18
distinct areas of Iran. This study was conducted on 130,570 adults 35 years and older. A structured questionnaire
was applied to collect data. The concentration index (C) was used to quantify and decompose socioeconomic
inequalities in drug use.
Results: The prevalence experience of drug use was 11.9%. The estimated C for drug use was − 0.021. The
corresponding value of the C for women and men were − 0.171 and − 0.134, respectively. The negative values of
the C suggest that drug use is more concentrated among the population with low socioeconomic status in Iran
(p < 0.001). For women, socioeconomic status (SES) (26.37%), province residence (− 22.38%) and age (9.76%) had the
most significant contribution to socioeconomic inequality in drug use, respectively. For men, SES (80.04%), smoking
(32.04%) and alcohol consumption (− 12.37%) were the main contributors to socioeconomic inequality in drug use.
Conclusions: Our study indicated that drug use prevention programs in Iran should focus on socioeconomically
disadvantaged population. Our finding could be useful for health policy maker to design and implement effective
preventative programs to protect Iranian population against the drug use.
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Background
Drug use (refers to any scope of use of illegal drugs: her-
oin, amphetamines, barbiturates, cannabis, cocaine, hal-
lucinogens, and opioids) is one of the major health,
psychosocial and socioeconomic problems in the world,
and can lead to several problems and complications for
addicts, their families and society [1, 2]. There exists sex
differences in the drug use in the communities; the rate
of drug use in men has been significantly higher than
women even though this sex gap has been steadily de-
creasing [3].
Iran is one of the countries where drug use preva-
lence has increased in recent years;this is due to vari-
ous reasons such as shares border with Afghanistan
in the Eastern of Iran which is the largest producer
country of opium in the world, and a major route for
substance transport to Europe [4]. Based on the
World Health Organization (WHO), Iran has the
highest rate of opium abusers in the world, and
opium use in Iran is three times the global average
[5]. The statistics show that there are about 2 million
people use illicit drugs at a daily basis in Iran, which
is about 2.7% of the population [6].
Providing knowledge about the determinants influ-
encing drug use in the society can enable health pol-
icymakers to the development and the
implementation evidence-based preemptive programs
[7]. In the area of addiction tendency, various hypoth-
eses have been expressed that none of them alone
can explain this problem [8, 9]. Several studies have
indicated the predictive nature of socioeconomic sta-
tus (SES) against drug use such as alcohol consump-
tion, opium, cigarette smoking, and cannabis;
however, the association between SES and drug use is
complex [10–14]. For example, the prevalence of
cigarette smoking is higher among groups with low
SES and they maybe more exposure to harms related
cigarette smoking [10]. A higher addiction rate also
found among individuals with low SES [12]. Contrary
to these results, some studies [11] reported higher al-
cohol consumption and cannabis use among high
SES.
Although studies have been conducted on the rela-
tionship between SES and drug use in Iran, these
studies have used a small sample size with a focus on
only one sex (especially men) [15–17]. Thus, more
studies are required to predict socioeconomic-related
inequalities in drug use among adults in Iran. Given
the widespread incongruities among the findings of
researches, our study focused on socioeconomic-
related inequality to the drug use in among Iranian
adult’s population using a large sample size obtained
from the Prospective Epidemiologic Research Study
(PERSIAN Cohort).
Methods
Study setting
The PERSIAN Cohort is the largest and most im-
portant cohort among 18 distinct areas of Iran. This
study launched nationwide by the Ministry of Health
and Medical Education (MoHME) in Iran to provide
information about Non-communicable Diseases
(NCDs) among Iranian adults (aged 35 and above).
The PERSIAN Cohort Study is a prospective study
with purpose to include 180,000 Iranians aged 35–
70 years from 18 geographically distinct areas of
Iran. While the MoHME oversees the project, re-
searchers at local Iranian medical universities carry
it out. The cohort has started in 2014 and collects
information between 5000 and 10,000 people from
all Iranian ethnic groups in each district area. The
financial support for the study is provided by the
MoHME, and the deputy of research in the medical
universities in the 18 distinct areas of Iran. The
protocol of PERSIAN Cohort study (including: objec-
tives, outcomes of interest, design of study, site se-
lection, participant selection, sample size, sampling
methods, inclusion criteria, and quality assurance
and quality control was published in American Jour-
nal of Epidemiology [18] and Archives of Iranian
Medicine [19]. The Iranian people comprise individ-
uals of many ethnicities. Appendix 1 shows the char-
acteristics of cohort sites in Iran.
Study tools
The cohort questionnaire is administered by trained
interviewers.
Physical activity
Physical activity was measured weekly based on all
the physical activity related to exercise, work, and re-
creation in the past 24 h. Physical activity question-
naire includes 19 light, moderate, and severe
activities. MET is the amount of oxygen consumed at
rest (about 3.5 ml 02/kg/min) and equals to resting
metabolic rate. Physical activity levels were classified
as low (24–36.5 MET-hours per week), moderate
(MET-36.6-44.9 h per week) and heavy (MET- ≥ 45 h
per week) [18].
Drug use variable
To assess whether or not the subjects had a history of
drug use (included: heroin, amphetamines, barbiturates,
cannabis, cocaine, hallucinogens, and Opioids), a ques-
tion was asked: “Have you used illicit drug more than
one time during a lifetime?” The reply options for each
drug question was “Yes” or “No”.
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Cigarettes smoking
Smoking status evaluated based the one National Health
Interview Survey (NHIS). If respondents smoked ≥100
cigarettes in their lifetime, they were defined as smokers.
The ex-smoker refers to an individual who has given up
a cigarette smoking. Former smokers were previous
smokers but are no longer smoking [20].
Water pipe smoking
To assess whether or not the participants had experi-
enced water pipe smoking, we used one questions “Have
you ever water pipe smoking at during a lifetime?” which
the response category was yes or no.
Alcohol consumption
To assess whether or not the respondents had a history
of alcohol consumption a question was asked: “Have you
consumed alcoholic drinks more than one time during a
lifetime?” The reply options for alcohol consumption
question was “Yes” or “No”.
Socioeconomic status index
A principal component analysis (PCA) method was used
to construct an SES index of respondents in the Cohort
study. Available information on, infrastructure facilities
(source of drinking water, sanitation facility), housing
condition (e.g. the number of rooms, type of home own-
ership) and ownership of a range of durable assets (e.g.
dishwasher, car, television), and education level in the
dataset was used in the construction of SES variable for
each participants. Participants of the study categorized
into five SES quintiles, from the lowest (1st quintile) to
the highest (5th quintile) SES groups.
Measuring socioeconomic-related inequality in drug use
Socioeconomic-related inequality in drug use was esti-
mated using the Concentration index (C) approach and
the Concentration curve [19]. The concentration curve
is a two-dimensional graph. The horizontal axis shows
the cumulative percentage of the population ranked
from the poorest to the richest, and the vertical axis in-
dicates the cumulative percentage of the health variable
(in the present study: drug use). The 45-degree line rep-
resents full equality in the distribution of drug use. If the
drug abuse rate is higher among socioeconomically dis-
advantaged individuals, the concentration curve places
above the equality line. The C is extracted from the
Concentration curve and equals twice the space between
the Concentration curve and the equality line (45-de-
gree). If the index is zero, this means that the variable is
distributed equally among SES groups. The following
formula was used to measured inequality and estimated
the C (equation (1):
C ¼ 2 cov yirið Þ
μ
ð1Þ
Where yi is health variable for the person i, μ it’s mean
of the health outcome variable and ri the fractional rank.
Considering that the drug use in our study was a binary
variable, the minimum and maximum values of the C
does range between − 1 and + 1. Thus, the C was nor-
malized by dividing the estimated value of the concen-
tration index by 1 − μ (equation (2) [20].
Cn ¼ CI1−μ ð2Þ
To determine the contribution of each factor to socio-
economic inequality in drug use, we decompose the esti-
mated Cn (equation (3) [21]. If we have a regression
model relating a set of demographic (age, sex, marital
status), behavioural (cigarette smoking, water pipe smok-
ing) and socioeconomic variables, xk, to the drug use sta-
tus of individuals such as:
y ¼ αþ
X
k
βkxk þ ε ð3Þ
where βk are marginal effects obtained from the logistic
regression. The Cn for drug use can be decomposed as:
Cn ¼
X
K
βKXK
μ
 
CK
1−μ
þ
GCε
μ
1−μ
ð4Þ
Where xk is mean of each of the independent vari-
ables, Ck is the concentration index for the explanatory
variable xk, and GCε is the generalized C for ε. The first
part of equation ((4) indicates the contribution of each
explanatory factors to the overall Cn. Based on equation
(4, the Cn can be decomposed into two components.
The first component,
X
k
ðβkxk
μ
ÞCk=1−μ , indicated how
the Cn is explained by the relationship between the inde-
pendent variable and explanatory variables and the sys-
tematic changes of independent variables in the
distribution of socioeconomic groups. The negative
(positive) contribution of independent variable to the Cn
indicated that the distribution of independent variables
across SES and the relationship of this variable to drug
use are likely to contribute to the higher (lower) concen-
tration of drug use among the poor. The second compo-
nent or GCε/μ/1 − μ indicated the inequality that is not
explained by independent variables included in the
model. Multivariable logistic regressions were then used
to examine adjusted odds ratios (OR).
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Ethical statement
While each cohort center received the ethical approval
from local universities, for the purpose of this study and
pooling all PERSIAN data, the ethics committee of Ker-
manshah University of Medical Sciences approved the
study (IR.KUMS.REC.1397.187).
Results
The mean age of participants was 49.7 years [SD: 9.2].
Approximately55.5% of the participants were women.
90.9 and 20.2% of participants were married, and
illiterate, respectively. In addition, 14% of the partici-
pants in PERSIAN cohort were a current smoker. 11.9%
(24.1% among men versus 2.2% among women) of the
population had a history of drug use.
Table 1 reported the prevalence of drug use among
adults in Iran by the respondents’ characteristics in the
PERSIAN cohort. As the prevalence of drug use linearly
increased by age in women but did not change signifi-
cantly in men (P = 0.7). The highest prevalence of drug
use was in married people. The prevalence of drug use
was decreased by education level.
Figure 1 shows sex difference in the prevalence of drug
use in different provinces of Iran. As shown in the fig-
ure, the prevalence of drug use among men was found
to be higher in Kerman (KE), Yazd (YA), Kohgiluyeh
Table 1 Distribution of the demographic characteristics among the participants and the prevalence of drug use in Iran by the
respondents’ characteristics in the PERSIAN cohort
Variables N (%) Total
prevalence
Male
prevalence
Female
prevalence
Total 130,570 (100) 11.9 (15600) 24.1 (13998) 2.2 (1602)
Age group 35–40 27,005 (20.7) 9.3 20.6 1.1
41–45 24,212 (24.2) 11.7 25.0 1.5
46–50 22,645 (22.6) 12.5 26.2 1.8
51–55 20,297 (15.5) 12.8 25.2 2.7
55–60 17,570 (13.5) 13.5 25.3 3.4
61–65 12,271 (9.4) 13.1 23.7 3.8
> 66 6570 (5.0) 12.4 21.1 4.2
Marital status Married 118,769 (91.0) 12.6 23.9 2.0
Single 2895 (2.2) 6.1 27.4 0.4
Divorced/widowed 8906 (6.8) 5.7 34.3 4.1
Years of education Illiterate (0 year) 26,666 (20.2) 8.3 23.6 3.2
1–5 years 41,975 (31.9) 11.2 26.7 2.3
6–9 years 23,938 (18.2) 17.9 30.3 2.0
10–12 years 22,552 (17.1) 14.4 24.2 1.2
> = 13 years 16,659 (12.6) 7.6 12.0 0.6
Cigarette smoking Never smoker 102,141 (78.2) 4.5 10.0 2.0
Current smoker 18,331 (14.0) 43.3 44.9 12.2
Former smoker 10,097 (7.8) 30.6 33.1 7.7
Alcohol consumption No 118,772 (91.0) 8.4 17.9 2.2
Yes 11,795 (9.0) 47.7 48.8 11.9
Water pipe smoking No 115,979 (88.8) 9.2 20.2 1.7
Yes 14,581 (11.2) 34.0 40.5 12.9
Physical activity Daily
(MET-hours per day)
24–36.5 43,226 (33.1) 14.3 26.9 3.0
36.6–44.9 61,532 (47.2) 8.3 21.8 1.8
≥45 25,673 (19.7) 16.8 23.4 1.9
Economic status 1st quintile (the poorest) 26,159 (20.0) 11.7 30.0 3.1
2nd quintile 26,148 (20.0) 12.8 27.5 2.4
3rd quintile 26,105 (20.0) 12.2 24.9 2.1
4th quintile 26,095 (20.0) 12.7 23.8 1.8
5th quintile (the richest) 26,063 (20.0) 10.3 17.6 1.2
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and Boyer-Ahmad (KBA), and Chaharmahal and Bakh-
tiari (CB) provinces. Among women, higher prevalence
was found in the provinces of Sistan and Baluchestan
(SB), Kerman (KR) and Gilan (GU).
The estimated C was equal to − 0.021, suggesting the
higher concentration of drug use among the population
with low SES. Moreover, socioeconomic inequality in
drug use was found to be higher in women than in men.
This is also evident in Fig. 2 where the Concentration
curve for drug use for female lies above to the Concen-
tration curve for male. The 45° line (blue line) is the per-
fect inequality that is equal to average health status.
Fig. 1 Prevalence of drug use in men and women across 15 provinces in Iran
Fig. 2 Concentration curves for drug use among men and women in Iran
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All provinces, except for Khouzestan (KH) and West
Azarbaijan (WA), the estimated value of Cn showed that
druguse is concentrated among low SES groups. The
sign of the Cn was positive for women in the provinces
such as Kermanshah (KSH), Mazandaran (MA), Khouze-
stan (KH), Hormozgan (HO), West Azerbaijan (WA)
and Kohgiluyeh and Boyer-Ahmad (KB). For men, the
Cn value was positive for Khuzestan (KH) and West
Azerbaijan provinces only. The pattern of
socioeconomic-related inequality for men in the cohort
population was similar to women (see Fig. 3).
Determinants of socioeconomic-related inequalities
Due to the Simpson paradox [22] on the total value
of the Cn, decomposition analysis was performed for
men and women, separately. Simpson paradox or re-
versal paradox is a phenomenon in probability and
statistics, in which a trend appears in several differ-
ent groups of data but disappears or reverses when
these groups are combined. Table 2 presents the re-
sults of the decomposition of the Cn. The results of
Ck revealed that the prevalence of variables like be-
ing single, widowed/divorced, underweight, older
ages, smoking and higher levels of physical activity is
more concentrated among low SES groups. In con-
trast, the prevalence of alcohol consumption, obesity
and overweight is higher in the high SES groups.
The values of Ck indicated that higher concentra-
tions of obese and overweight individuals among
high-SES.
For women, SES (26.37%), residence province (− 22.38%)
and age (9.76%) had the most significant contribution to so-
cioeconomic inequality in drug use, respectively. For men,
SES (80.04%), smoking (32.04%) and alcohol consumption
(− 12.37%) were the main contributors to socioeconomic
inequality in drug use in Iran.
Discussion
Our study indicated that 11.9% (24.1% among men ver-
sus 2.2% among women) of the adult population in Iran
used the illicit drug more than one time in their lifetime.
In addition, 14 and 9% of the participants were a current
smoker and had history of alcohol consumption, respect-
ively. These results are in line with the findings of earlier
studies investigating the drug use, cigarette smoking and
alcohol consumption among Iranian adults. For example,
the obtained results of study carried out by Jalilian et al.
[15] indicated that 19.4 and 10.1% of the Iranian adults
reported history of cigarette smoking, and alcohol drink-
ing respectively. As well as, Mohebbi et al. [16] carried
out a study on 2065 adults aged 18 years and older in
Iran and reported that lifetime experience of drug use
was 12.9% (21.5% among men versus 4% among
women).
Drug use is a concerning health problem among Iran-
ian population [23]. Moreover, since the alcohol drink
and narcotics are illegal in Iran we thought that fear of
confrontation with legal authorities may affect our study
participation rate [24]. These results can be warning to
health policy makers in Iran.
Fig. 3 Socioeconomic inequalities in drug use in men and women across 15 provinces in Iran
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Our findings suggested that drug use is more con-
centrated among the population with low socioeco-
nomic status in Iran. This result is similar to the
results reported by other studies. For example, Law-
ana and Booysen in their study in South African re-
ported alcohol use is more concentrated among the
lower socioeconomic groups [25]. Furthermore, Nik-
farjam et al. in their study in total 12,293 samples in
Iran reported the relative frequency of alcohol use
among males was about 8 times higher than females
[26]. Evidence points to the lower socio-economic
groups suffer multiple deprivations [27]. For example,
studies have been indicated association between lower
SES and the following risk factors: cigarettes smoking;
drug use problems; psychosocial stress; obesity; lack
of social support; and less use of health care services
[27–29]. Our study indicated that the drug use is
more concentrated among the lower SES groups.
Concerted government efforts, within the health sec-
tor (for example, pay special attention to groups with
lower SES for drug addiction treatment) is required
for eliminate inequality.
Furthermore, SES.
For men, SES (80.04%), smoking (32.04%) and alcohol
consumption (− 12.37%) were the main contributors to
socioeconomic inequality in drug use.
Also, the results of our study indicated that the SES
had more contribution to socioeconomic inequality in
drug use among men compared to women (80.04%
VS 26.37%). Moreover, drug use prevalence was
higher among the male population (24.1% among
men versus 2.2% among women). This finding is in
line with other studies that indicated that men are at
higher risk of drug use than women [11, 30, 31]. A
study by Do et al also indicated a higher proportion
of drug use among men as compared than women in
Vietnam [14]. Thus, specific strategies in order to
prevention of drug use for this group should be dis-
pensed by policy-makers.
Another finding of current study was indicated the
prevalence of drug use was decreased by increased
education level. In this regard, Lee et al. in their lon-
gitudinal study on 808 male and females elementary
school students followed to age 30 indicated earning
a high school diploma lessens the risk of drug use
problems which contribute to economic instability in
young adulthood [28]. Also, in line with our findings
Kessler et al. carried out a study on 9282 English
speakers 18 years and older in the coterminous United
States and reported that lower education was associ-
ated with increased comorbid mental health and drug
use problems [32]. Several studies have underlined
higher education level as a protective factor against
drug use [16, 33]. Our findings suggest that the drug
use prevention program should focus on less-educated
adults in Iran.
Our study also showed that the prevalence of drug
use linearly increased by age in women but did not
change significantly in men. Moreover, the highest
prevalence of drug use was in married group. These
findings are somewhat consistent with other studies
in Iran. For example, Amin-Esmaeili et al. reported
that the odds of drug use related-disorders were
higher in previously married as compared to currently
married or single adults in Iran [34]. However,
Mohebbi et al. demonstrated that divorced or
widowed adults reported a higher rate of opium use
which is inconsistent with the present study found
[16]. It is also inconsistent with our findings, Moteva-
lian et al. in their study indicated that the prevalence
of drug use increased in men and women with an in-
crease in age [35].
Because of proximity to Afghanistan (the country
with the greatest opium production in the world) Iran
seems to have the conditions for being a significant
place for drug use [4]. As our findings show, drug
use was more prevalent in neighboring provinces with
Afghanistan.
Study limitations
Although our study has several strengths including
large sample size, the results reported in this study
should be interpreted in light of some limitations.
First, our study is cross-sectional nature; thus, no
causal inference can be derived from the associations
reported in the paper. Second, self-reporting infor-
mation may be subject to recall bias. Third, since
the inclusion age of our study was 35 years and
older, it may affect one affect the results and the es-
timated lifetime prevalence and type of drug use. Fi-
nally, the our study investigated drug use and
alcohol consumption history more than one time
during lifetime using yes-no scale, which was the
main limitations of the current study and asks for
more attention.
Conclusions
There are multiple factors to explain the drug use in-
equality among Iranian people. The present study
confirmed the applicability of the SES to explain drug
use among Iranian population. We found that higher
rate of drug use among low-SES. Thus, drug use pre-
vention programs in Iran should target low SES
adults in order to reduce inequalities in drug use in
Iran. Our finding could be useful for health policy
maker to design and implement effective preventative
programs to protect Iranian population against the
drug use.
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Table 3 The cohort population in the study provinces
Row Province *Population Cohort site *Population Cohort population Main Ethnicities
1 Ardabil 1,270,420 Ardabil 529,374 8192 Azeri (Turk)
2 Chaharmahal and Bakhtiari 947,763 Sharekord 93,104 6664 Lur
3 East Azerbaijan 3,909,652 Khameneh 3056 14,978 Azeri (Turk)
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6 Hormozgan 1,776,415 Bandare Kong 19,213 3570 Arab
7 Kerman 3,164,718 Rafsanjan 161,909 9982 Fars (Persian)
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Sabzevar 243,700 784 Fars (Persian)
12 Sistan and Balouchestan 2,775,014 Zahedan 587,730 8318 Balouch
13 West Azerbaijan 3,265,219 Ghoushchi 2787 3662 Azeri (Turk)
14 Yazd 1,138,533 Shahedieh, Yazd 18,309 9901 Fars (Persian)
15 Kohgiluyeh and Boyer-Ahmad 7,313,052 Dena 52,242 421 Lur
*The frequency of population is according to Iranian Population and Housing Census in 2016
Moradinazar et al. Substance Abuse Treatment, Prevention, and Policy           (2020) 15:39 Page 10 of 11
Sciences, Fasa, Iran. 15Health Services Management, Arak University of
Medical Sciences, Arak, Iran.
Received: 26 October 2019 Accepted: 28 May 2020
References
1. Ahmadpanah M, Mirzaei-Alavijeh M, Allahverdipour H, Jalilian F, Haghighi M,
Afsar A, et al. Effectiveness of coping skills education program to reduce
craving beliefs among addicts referred to addiction centers in Hamadan: a
randomized controlled trial. Iran J Public Health. 2013;42(10):1139.
2. Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and
responses. Prev Med. 2015;80:5–9.
3. Lal R, Deb KS, Kedia S. Substance use in women: current status and future
directions. Indian J Psychiatry. 2015;57(Suppl 2):S275.
4. Amirabadizadeh A, Nezami H, Vaughn MG, Nakhaee S, Mehrpour O.
Identifying risk factors for drug use in an Iranian treatment sample: a
prediction approach using decision trees. Substance use & misuse. 2018;
53(6):1030–40.
5. Soroosh D, Neamatshahi M, Zarmehri B, Nakhaee S, Mehrpour O. Drug-
induced prolonged corrected QT interval in patients with methadone and
opium overdose. Subst Abuse Treat Prev Pol. 2019;14(1):8.
6. Eskandarieh S, Jafari F, Yazdani S, Hazrati N, Saberi-Zafarghandi MB.
Compulsory maintenance treatment program amongst Iranian injection
drug users and its side effects. Int J High Risk Behav Addiction. 2014;3(4):
e21765.
7. Kok G, Gottlieb NH, Peters GJ, Mullen PD, Parcel GS, Ruiter RA, et al. A
taxonomy of behaviour change methods: an intervention mapping
approach. Health Psychol Rev. 2016;10(3):297–312.
8. Gullo MJ, Matveeva M, Feeney GF, Young RM, Connor JP. Social cognitive
predictors of treatment outcome in cannabis dependence. Drug Alcohol
Depend. 2017;170:74–81.
9. Otten R, Mun CJ, Dishion TJ. The social exigencies of the gateway
progression to the use of illicit drugs from adolescence into adulthood.
Addict Behav. 2017;73:144–50.
10. Almeida-Filho N, Lessa I, Magalhães L, Araújo MJ, Aquino E, James SA, et al.
Social inequality and alcohol consumption-abuse in Bahia, Brazil. Soc
Psychiatry Psychiatr Epidemiol. 2005;40(3):214–22.
11. Do HN, Nathan N, Van Nguyen B, Le HT, Nguyen HQ, Nguyen AT, et al.
Sociodemographic inequalities in substance use among young people in
Vietnam. Child Youth Serv Rev. 2018;94:644–9.
12. Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M. Socioeconomic status and
smoking: a review. Ann N Y Acad Sci. 2012;1248(1):107–23.
13. Patrick ME, Wightman P, Schoeni RF, Schulenberg JE. Socioeconomic status
and substance use among young adults: a comparison across constructs
and drugs. J Stud Alcohol Drugs. 2012;73(5):772–82.
14. Redonnet B, Chollet A, Fombonne E, Bowes L, Melchior M. Tobacco, alcohol,
cannabis and other illegal drug use among young adults: the
socioeconomic context. Drug Alcohol Depend. 2012;121(3):231–9.
15. Jalilian F, KaramiMatin B, Ahmadpanah M, Ataee M, AhmadiJouybari T,
Eslami AA, et al. Socio-demographic characteristics associated with
cigarettes smoking, drug abuse and alcohol drinking among male medical
university students in Iran. J Res Health Sci. 2015;15(1):42–6.
16. Mohebbi E, Haghdoost AA, Noroozi A, Vardanjani HM, Hajebi A, Nikbakht R,
et al. Awareness and attitude towards opioid and stimulant use and lifetime
prevalence of the drugs: a study in 5 large cities of Iran. Int J Health Policy
Manag. 2019;8(4):222.
17. Rostami M, Karamouzian M, Khosravi A, Rezaeian S. Gender and
geographical inequalities in fatal drug overdose in Iran: A province-
level study in 2006 and 2011. Spatial Spatio-Temporal Epidemiology.
2018;25:19–24.
18. Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost
A, et al. Prospective epidemiological research studies in Iran (the PERSIAN
cohort study): rationale, objectives, and design. Am J Epidemiol. 2017;187(4):
647–55.
19. Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B,
et al. The PERSIAN cohort: providing the evidence needed for healthcare
reform. Arch Iran Med. 2017;20(11):691.
20. Ryan H, Trosclair A, Gfroerer J. Adult current smoking: differences in
definitions and prevalence estimates—NHIS and NSDUH, 2008. J Environ
Public Health. 2012;2012:918368 11 pages.
21. Wagstaff A, Paci P, Van Doorslaer E. On the measurement of inequalities in
health. Soc Sci Med. 1991;33(5):545–57.
22. Fiedler K, Walther E, Freytag P, Nickel S. Inductive reasoning and judgment
interference: experiments on Simpson’s paradox. Personal Soc Psychol Bull.
2003;29(1):14–27.
23. Sharifi H, Shokoohi M, Ahmad RafieiRad A, SargolzaieMoghadam M,
Haghdoost AA, Mirzazadeh A, Karamouzian M. Methamphetamine use
among Iranian youth: a population-based knowledge, attitude, and practice
study. Subst Use Misuse. 2017;52(9):1214–21.
24. Allahverdipour H, Jalilian F, Shaghaghi A. Vulnerability and the intention to
anabolic steroids use among Iranian gym users: an application of the theory
of planned behavior. Subst Use Misuse. 2012;47(3):309–17.
25. Lawana N, Booysen F. Decomposing socioeconomic inequalities in alcohol
use by men living in south African urban informal settlements. BMC Public
Health. 2018;18(1):993.
26. Nikfarjam A, Hajimaghsoudi S, Rastegari A, Haghdoost AA, Nasehi AA,
Memaryan N, et al. The frequency of alcohol use in Iranian urban
population: the results of a national network scale up survey. Int J Health
Policy Manag. 2017;6(2):97.
27. Ataguba JE, Akazili J, McIntyre D. Socioeconomic-related health inequality in
South Africa: evidence from general household surveys. Int J Equity Health.
2011;10(1):48.
28. Lee JO, Herrenkohl TI, Kosterman R, Small CM, Hawkins JD. Educational
inequalities in the co-occurrence of mental health and substance use
problems, and its adult socio-economic consequences: a longitudinal study
of young adults in a community sample. Public Health. 2013;127(8):745–53.
29. Mackenbach JP. Socio-economic health differences in the Netherlands: a
review of recent empirical findings. Soc Sci Med. 1992;34(3):213–26.
30. Hicks BM, Blonigen DM, Kramer MD, Krueger RF, Patrick CJ, Iacono WG, et al.
Gender differences and developmental change in externalizing disorders
from late adolescence to early adulthood: a longitudinal twin study. J
Abnorm Psychol. 2007;116(3):433.
31. King KM, Chassin L. A prospective study of the effects of age of initiation of
alcohol and drug use on young adult substance dependence. J Stud
Alcohol Drugs. 2007;68(2):256–65.
32. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and
comorbidity of 12-month DSM-IV disorders in the National Comorbidity
Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.
33. Drope J, Liber AC, Cahn Z, Stoklosa M, Kennedy R, Douglas CE, Henson R,
Drope J. Who's still smoking? Disparities in adult cigarette smoking
prevalence in the United States. CA Cancer J Clin. 2018;68(2):106–15.
34. Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R,
Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran:
prevalence, correlates, comorbidity and service utilization results from the
Iranian mental health survey. Addiction. 2016;111(10):1836–47.
35. Motevalian A, Sahebi R, RahimiMovaghar A, Yunesian M. Age, period, and
cohort effects on alcohol and drug use among students of Tehran
university of medical sciences from 2006 to 2009. Iran J Epidemiol. 2015 Sep
15;11(2):99–108.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Moradinazar et al. Substance Abuse Treatment, Prevention, and Policy           (2020) 15:39 Page 11 of 11
